Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Postoperative chemoradiotherapy after surgical resection of gastric adenocarcinoma: can LV5FU2 reduce the toxic effects of the MacDonald regimen? A report on 23 patients.

Dahan L, Atlan D, Bouché O, Mitry E, Ries P, Artru P, Richard K, Lledo G, Nguyen T, Rougier P, Seitz JF.

Gastroenterol Clin Biol. 2005 Jan;29(1):11-5.

2.

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA.

N Engl J Med. 2001 Sep 6;345(10):725-30.

3.

Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.

Leong CN, Chung HT, Lee KM, Shakespeare TP, Mukherjee RK, Wong LC, Lu JJ, Tey J, Lim R, So JB, Back MF.

Cancer J. 2008 Jul-Aug;14(4):269-75. doi: 10.1097/PPO.0b013e318178d23a.

PMID:
18677137
4.

Postoperative chemoradiotherapy for gastric cancer.

Park SH, Kim DY, Heo JS, Lim DH, Park CK, Lee KW, Choi SH, Sohn TS, Kim S, Noh JH, Kim YI, Park JO, Kim K, Kim WS, Jung CW, Im YH, Lee MH, Park K, Park CH, Kang WK.

Ann Oncol. 2003 Sep;14(9):1373-7.

5.

An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.

Kim S, Lim DH, Lee J, Kang WK, MacDonald JS, Park CH, Park SH, Lee SH, Kim K, Park JO, Kim WS, Jung CW, Park YS, Im YH, Sohn TS, Noh JH, Heo JS, Kim YI, Park CK, Park K.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1279-85. Epub 2005 Aug 15.

PMID:
16099596
7.

Postoperative chemotherapy followed by conformal concomitant chemoradiotherapy in high-risk gastric cancer.

Quero L, Bouchbika Z, Kouto H, Baruch-Hennequin V, Gornet JM, Munoz N, Cojean-Zelek I, Houdart R, Panis Y, Valleur P, Aparicio T, Maylin C, Hennequin C.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):574-80. doi: 10.1016/j.ijrobp.2011.07.031. Epub 2011 Nov 16.

PMID:
22099038
8.

Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.

Ajani JA, Winter K, Okawara GS, Donohue JH, Pisters PW, Crane CH, Greskovich JF, Anne PR, Bradley JD, Willett C, Rich TA.

J Clin Oncol. 2006 Aug 20;24(24):3953-8.

9.

Adjuvant chemoradiotherapy in patients with stage III or IV radically resected gastric cancer: a pilot study.

Orditura M, De Vita F, Muto P, Vitiello F, Murino P, Lieto E, Vecchione L, Romano A, Martinelli E, Renda A, Ferraraccio F, Del Genio A, Ciardiello F, Galizia G.

Arch Surg. 2010 Mar;145(3):233-8. doi: 10.1001/archsurg.2010.2.

PMID:
20231623
10.

Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO.

Kollmannsberger C, Budach W, Stahl M, Schleucher N, Hehr T, Wilke H, Schleicher J, Vanhoefer U, Jehle EC, Oechsle K, Trarbach T, Boehlke I, Kanz L, Hartmann JT, Bokemeyer C.

Ann Oncol. 2005 Aug;16(8):1326-33. Epub 2005 May 26.

11.

The management of gastric adenocarcinoma with postoperative chemoirradiation. A non-randomized comparison of oral UFT and 5-FU.

Surenkok S, Beyzadeoglu M, Oysul K, Ozyigit G, Ataergin S, Arpaci F, Ozet A.

Tumori. 2008 Jan-Feb;94(1):70-4.

12.

Adjuvant chemo-radiotherapy in patients with gastric cancer.

Capizzello A, Tsekeris PG, Pakos EE, Papathanasopoulou V, Pitouli EJ.

Indian J Cancer. 2006 Oct-Dec;43(4):174-9.

13.

[Evaluation of tolerance and efficacy of postoperative combined radiotherapy and chemotherapy in locally advanced gastric cancer].

Wydmański J, Suwiński R, Miszczyk L, Maka B, Maciejewski B.

Przegl Lek. 2005;62(12):1431-5. Polish.

PMID:
16786766
14.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
15.

A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer.

Jansen EP, Boot H, Saunders MP, Crosby TD, Dubbelman R, Bartelink H, Verheij M, Cats A.

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1424-8. Epub 2007 Aug 6.

PMID:
17689023
16.

Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancer.

Martenson JA, Swaminathan R, Burch PA, Santala RG, Schroeder G, Pitot HC, Wright K, Kugler JW, Stella PJ, Garton GR.

Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):615-8.

PMID:
9112460
17.

Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group.

Oechsle K, Bokemeyer C, Hartmann JT, Budach W, Trarbach T, Stahl M, Boehlke I, Kollmannsberger C; German AIO/ARO/CAO group.

J Cancer Res Clin Oncol. 2009 Feb;135(2):163-72. doi: 10.1007/s00432-008-0463-6. Epub 2008 Sep 30.

PMID:
18825411
18.

Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).

Vestermark LW, Jacobsen A, Qvortrup C, Hansen F, Bisgaard C, Baatrup G, Rasmussen P, Pfeiffer P.

Acta Oncol. 2008;47(3):428-33. doi: 10.1080/02841860701798866.

PMID:
18348002
19.

Conformal radiotherapy in the adjuvant treatment of gastric cancer: Review of 82 cases.

Kassam Z, Lockwood G, O'brien C, Brierley J, Swallow C, Oza A, Siu L, Knox JJ, Wong R, Cummings B, Kim J, Moore M, Ringash J.

Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):713-9. Epub 2006 Apr 19.

PMID:
16626887
20.

Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: a feasibility study.

Lupattelli M, Maranzano E, Bellavita R, Natalini G, Corgna E, Rossetti R, Trippa F, Mascioni F, Sidoni A, Anselmo P, Buzzi F, Brugia M, Latini P.

Tumori. 2005 Nov-Dec;91(6):498-504.

PMID:
16457149
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk